Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial - Highland, KB; Distler, O; Kuwana, M (The Lancet Respiratory Medicine, 2021)